Related Experiment Video
Updated: May 15, 2026
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Targeting cancer cells with controlled release nanocapsules based on a single aptamer
Frank J Hernandez1, Luiza I Hernandez, Alessandro Pinto
1Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine University of Iowa, Iowa City, IA 52242, USA.
Chemical Communications (Cambridge, England)
|January 9, 2013
Summary
This study introduces an engineered molecular gate using aptamers to precisely target cancer cells with nanoparticles. This novel nanovalve system enables controllable drug delivery, overcoming key challenges in nanomedicine.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Engineering
Background:
- Molecular gates are explored for drug delivery, with aptamer-based systems showing promise for nanocapsule applications.
- Current challenges in drug delivery include precise targeting and controlled release of therapeutic payloads.
Purpose of the Study:
- To demonstrate an engineered single molecular gate for targeted nanoparticle delivery to cancer cells.
- To develop a controllable drug delivery system based on switchable aptamer nanovalves.
Main Methods:
- Utilizing a switchable aptamer nanovalve approach to engineer a molecular gate.
- Directing nanoparticles specifically to cancer cells for payload delivery.
Main Results:
- Successful demonstration of an engineered single molecular gate.
- Achieved controllable nanoparticle delivery to cancer cells.
Conclusions:
- The aptamer-based molecular gate offers a novel strategy for targeted cancer therapy.
- This nanovalve system provides a controllable platform for nanoparticle-based drug delivery.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...